<DOC>
	<DOCNO>NCT00802672</DOCNO>
	<brief_summary>The objective study demonstrate comparable safety efficacy Ciclopirox Olamine Cream ( Test Product ) Ciclopirox Cream 0.77 % ( Reference Product ) treatment subject tinea pedis , show superiority active treatment vehicle .</brief_summary>
	<brief_title>Safety Equivalence Generic Ciclopirox Olamine Cream Compared Reference Ciclopirox Cream 0.77 % Treatment Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Ciclopirox</mesh_term>
	<criteria>Male female least 10 year age , otherwise healthy Clinically mycologically confirm diagnosis symptomatic tinea pedis In good health clinically significant disease might interfere study evaluation Study participant legal guardian willing able read sign IRB approve ICF , include agreement comply study requirement indicate protocol . For subject 10 17 year age , assent form minor complete . History hypersensitivity allergy ciclopirox Had skin condition would interfere diagnosis assessment tinea pedis Had history dermatophyte infecton unresponsive antifungal treatment Had history alcoholism , drug abuse , problem would likely make subject unreliable study Had condition use medication , opinion Investigator , might interfere conduct result study placed prospective subject increase risk Was unwilling sign inform consent Female pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Tinea Pedis</keyword>
	<keyword>Ciclopirox Olamine</keyword>
</DOC>